Related Experiment Videos
Early stage primary pulmonary lymphoma
O Kawashima1, T Hirai, M Kamiyoshihara
1Department of Surgery, National Sanatorium Nishigunma Hospital, 2854 Kanai, Shibukawa, Gunma, 377, Japan.
Oncology Reports
|April 4, 1998
Summary
Optimal treatment for early stage primary pulmonary lymphoma involves complete surgical resection and postoperative chemotherapy. This combined approach significantly improves patient outcomes and prevents recurrence, offering a promising strategy for this rare condition.
Area of Science:
- Oncology
- Pulmonary Medicine
- Hematology
Background:
- Primary pulmonary lymphoma is a rare malignancy.
- Established treatment protocols for early-stage disease are lacking.
- Optimal management strategies require further investigation.
Purpose of the Study:
- To retrospectively analyze treatment outcomes in early-stage primary pulmonary lymphoma.
- To identify the optimal therapeutic approach for this rare condition.
- To evaluate the efficacy of combined resection and chemotherapy.
Main Methods:
- Retrospective review of five patients with early-stage primary pulmonary lymphoma.
- All patients underwent complete surgical resection and lymph node dissection.
- Analysis of pathological findings, including vascular invasion, and postoperative treatment regimens.
Main Results:
- Lymphatic and blood vessel invasion were present in all cases.
- Four patients receiving postoperative chemotherapy remain disease-free.
- One patient not receiving chemotherapy experienced extrapulmonary recurrence.
Conclusions:
- Complete resection combined with postoperative chemotherapy appears to be the treatment of choice.
- This multimodal approach may improve survival and reduce recurrence rates.
- Further research is warranted to confirm these findings in larger cohorts.